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Liu Y, Chidgey M, Yang VW, Bialkowska AB. Krüppel-like
factor 5 is essential for maintenance of barrier function in mouse
colon. Am J Physiol Gastrointest Liver Physiol 313: G478–G491,
2017. First published September 1, 2017; doi:10.1152/ajpgi.00172.
2017.—Krüppel-like factor 5 (KLF5) is a member of the zinc finger
family of transcription factors that regulates homeostasis of the
intestinal epithelium. Previous studies suggested an indispensable role
of KLF5 in maintaining intestinal barrier function. In the current
study, we investigated the mechanisms by which KLF5 regulates
colonic barrier function in vivo and in vitro. We used an inducible and
a constitutive intestine-specific Klf5 knockout mouse models (Villin-
CreERT2;Klf5fl/fl designated as Klf5IND and Villin-Cre;Klf5fl/fl as
Klf5IS) and studied an inducible KLF5 knockdown in Caco-2 BBe
cells using a lentiviral Tet-on system (Caco-2 BBe KLF5IND).
Specific knockout of Klf5 in colonic tissues, either inducible or
constitutive, resulted in increased intestinal permeability. The pheno-
type was accompanied by a significant reduction in Dsg2, which
encodes desmoglein-2, a desmosomal cadherin, at both mRNA and
protein levels. Transmission electron microscopy showed alterations
of desmosomal morphology in both KLF5 knockdown Caco-2 BBe
cells and Klf5 knockout mouse colonic tissues. Inducible knockdown
of KLF5 in Caco-2BBe cells grown on Transwell plates led to
impaired barrier function as evidenced by decreased transepithelial
electrical resistance and increased paracellular permeability to fluo-
rescein isothiocyanate-4 kDa dextran. Furthermore, DSG2 was sig-
nificantly decreased in KLF5 knockdown cells, and DSG2 overex-
pression partially rescued the impaired barrier function caused by
KLF5 knockdown. Electron microscopy studies demonstrated altered
desmosomal morphology after KLF5 knockdown. In combination
with chromatin immunoprecipitation analysis and promoter study, our
data show that KLF5 regulates intestinal barrier function by mediating
the transcription of DSG2, a gene encoding a major component of
desmosome structures.
NEW & NOTEWORTHY The study is original research on the
direct function of a Krüppel-like factor on intestinal barrier function,
which is commonly exerted by cell junctions, including tight junc-
tions, adherens junctions, and desmosomes. Numerous previous stud-
ies were focused on tight junctions and adherens junctions. However,
this study provided a new perspective on how the intestinal barrier
function is regulated by KLF5 through DSG2, a component of
desmosome complexes.
desmosomes; desmoglein-2
THE INTEGRITY OF THE gastrointestinal epithelium is under strin-
gent homeostatic control and is often impaired in disease
conditions such as inflammatory bowel disease (7, 17). Intes-
tinal barrier function, essential for both selective paracellular
permeability to electrolytes and water and defensibility against
luminal pathogens, is exerted by the polarized monolayer of
epithelial cells, with their paracellular space sealed by different
types of cell junctions (7). Intestinal cell junctions are com-
posed of tight junctions, adherens junctions, desmosomes, and
gap junctions (9, 36). The formation of the former three types
of cell junctions requires the assembly of protein complexes
consisting of transmembrane proteins and intracellular pro-
teins. Interaction of the intracellular proteins with cell cyto-
skeletons is essential for the maintenance of cellular structure
and epithelial barrier function (12). Many lines of evidence
indicate that loss of cell junction integrity results in intestinal
inflammation (11, 23, 35, 37), whereas intestinal barrier func-
tion is strengthened by upregulation of cell junction proteins
(34, 41).
Cell junctions are membranous protein complexes. Tight
junctions are distributed at apical foci on the basolateral mem-
brane of adjoining cells and include single transmembrane
proteins and intracellular scaffold proteins. Adherens junctions
are distributed on the basolateral membrane and composed of
transmembrane cadherins and intracellular armadillo proteins.
Like adherens junctions, desmosomes also contain cadherins
and armadillo proteins, as well as desmoplakin and other
intracellular proteins. Desmosomal cadherins consist of two
types of transmembrane proteins, desmocollins and desmog-
leins, which bind in either a heterotypic (6, 21) or homotypic
(20) manner. Among the four human desmoglein species and
the three human desmocollin species, human intestinal epithe-
lial cells mainly express desmoglein-2 (DSG2) and desmocol-
lin-2 (DSC2) (30). In addition to supporting a mechanical
linkage between epithelial cells, recent studies (14, 31)
specifically addressed the contribution of DSG2 in main-
taining intestinal barrier function. Antibody against the
extracellular domain of DSG2 was reported to adversely
affect tight junction integrity and impair intestinal epithelial
barrier function in Caco-2 cells, a common in vitro model of
intestinal epithelium (31).
Krüppel-like factor 5 (KLF5) is a zinc finger transcription
factor abundantly expressed in proliferative tissues. As a mul-
tifunctional transcription factor, KLF5 has been shown to
promote cell proliferation and tumorigenesis in tissues such as
urinary bladder, colon, and lung (3, 18, 27) while it functions
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as a tumor suppressor in breast and prostate cancers (4, 5).
Recently, it was shown that the roles of KLF5 extend beyond
oncoprotein or tumor suppressor activities. For example, KLF5
has been shown to be important for cell differentiation of
bladder urothelium (1), perinatal morphogenesis of lung (40),
postnatal maturation of eyelids (15), embryonic intestinal vil-
lus formation (2), maturation and maintenance of intestinal
crypt architecture (22), and proliferation and survival of mouse
intestinal epithelial stem cells (25). Furthermore, constitutive
Klf5 overexpression in mouse intestinal tissues resulted in less
colonic injury under inflammatory stimulus with dextran so-
dium sulfate (38). Previous studies from our laboratory ex-
plored the role of KLF5 in maintaining intestinal epithelial
homeostasis using the constitutive intestine-specific Klf5 dele-
tion mouse model (Klf5IS). Klf5IS mice were born at a normal
Mendelian ratio, but approximately two-thirds of them died
shortly after birth while the remainder survive to adulthood
primarily due to incomplete deletion of Klf5. Besides disrupted
intestinal epithelial architecture, the histology of surviving
Klf5IS mice showed signs of intestinal inflammation, includ-
ing the presence of neutrophil exudates in the glands of the
colon and infiltration of neutrophils in the epithelium and
lamina propria of the small and large intestines. Moreover, the
permeability across the intestinal epithelium of Klf5IS mice as
measured by fluorescein isothiocyanate (FITC)-dextran was
significantly higher than that in control mice (22). These results
suggest a role for KLF5 in maintaining intestinal epithelial
barrier function, although the mechanism by which KLF5
exerts this effect has not been determined. Most studies on the
regulation of cellular junction complexes have focused on
posttranscriptional mechanisms (as reviewed in Ref. 10); the
possibility of transcriptional regulation by a Krüppel-like fac-
tor has not yet been explored.
In this study, we used Klf5IND and Klf5IS mouse models to
study the role of KLF5 in maintaining intestinal epithelial
barrier function. Klf5 knockout was achieved with five consec-
utive days of tamoxifen injection to Klf5IND mice. The Klf5-
deleted mice showed reduced intestinal barrier function as
characterized by increased permeability to small-molecule
FITC-4 kDa dextran. Using quantitative PCR to analyze the
expression levels of cell junction components, we found that
Dsg2 gene had the greatest degree of downregulation and
similar expression pattern to that of Klf5. The absence of DSG2
in Klf5-depleted colonic tissues resulted in disrupted desmo-
somal morphology. Similar phenotype was observed with the
Klf5IS mouse model. Consistently, KLF5 knockdown Caco-2
BBe cells showed impaired barrier function, as characterized
by reduced transepithelial electrical resistance (TEER) and
increased permeability to FITC-4 kDa dextran. DSG2 level
was reduced and its distribution was disrupted in KLF5 knock-
down Caco-2 BBe cells as well. The absence of DSG2 in KLF5
knockdown cells resulted in disrupted desmosomal morphol-
ogy. Similar phenotype was observed with DSG2 knockdown
Caco-2 BBe cells, whereas DSG2 overexpression in KLF5
knockdown cells partially rescued epithelial barrier function.
Chromatin immunoprecipitation (ChIP) on the promoter se-
quences covering the potential binding sites further verified the
interaction of KLF5 and DSG2 promoter. In addition, sequence
analysis of DSG2 promoter identified three potential binding
sites of KLF5, and mutations of the potential binding sites
impaired KLF5-mediated activation of DSG2 promoter. Our
study is the first to demonstrate that KLF5 maintains intestinal
barrier function by controlling expression of a gene encoding
an essential desmosomal protein.
MATERIALS AND METHODS
Mice. All animal studies were performed following the protocols
approved by Stony Brook University Institutional Animal Care and
Use Committee. C57BL/6 mice carrying Klf5 alleles flanked by loxP
sites were crossed with Villin-CreERT2 or Villin-Cre mice carrying the
Cre recombinase gene fused with or without estrogen receptor T2
gene under regulation of Villin promoter to generate Villin-CreERT2;
Klf5fl/fl (Klf5IND) or Villin-Cre;Klf5fl/fl (Klf5IS) mice, respectively,
as previously described (22). Eight-week-old Villin-CreERT2 and
Klf5IND mice were injected with corn oil or 1 mg of tamoxifen
dissolved in 100 l of corn oil for five consecutive days before being
sacrificed on the 6th day since the first dose. Five-week-old Villin-Cre
and Klf5IS mice were sacrificed and tissue was collected on day 37
after birth.
Cell culture reagents. Caco-2 BBe and HEK 293T cells were
purchased from the ATCC (Manassas, VA). Caco-2 BBe and HEK
293T cells were maintained in Dulbecco’s modified Eagle’s medium
(Cellgro, Manassas, VA) supplemented with 10% fetal bovine serum
(Atlanta Biologicals, Norcross, GA) and 1% penicillin-streptomycin
(ThermoFisher Scientific, Waltham, MA).
Establishment of inducible KLF5 knockdown or inducible DSG2
knockdown in Caco-2 BBe cells. The inducible short-hairpin RNA
(shRNA) expression plasmid pLKO.1-tet-on was obtained from Ad-
dgene (Cambridge, MA) (42). The plasmids encoding shRNAs
(pLKO.1-tet-on-KLF5shRNA and pLKO.1-tet-on-DSG2shRNA)
were generated by ligation of the following oligonucleotides: shKLF5
sense 5=-CCGGCCCTGCCAGTTAACTCACAAACTCGAGTTT-
GTGAGTTAACTGGCAGGGTTTTT-3= and shKLF5 antisense 5=-
AATTAAAAACCCTGCCAGTTAACTCACAAACTCGAGTTT-
GTGAGTTAACTGGCAGGG-3= or shDSG2 sense 5=-CCGGCCTT-
ATTAAGGAAGTAGATTACTCGAGTAATCTACTTCCTTAA-
TAAGGTTTTT-3= and shDSG2 antisense 5=-AATTAAAAACCT-
TATTAAGGAAGTAGATTACTCGAGTAATCTACTTCCTTA-
ATAAGG-3= into pLKO.1-tet-on plasmid digested with AgeI and
EcoRI enzymes. pCD/NL-BH*  and pLTR-G plasmids were
kindly provided by Dr. Jakob Reiser (Food and Drug Administration,
Silver Spring, MD). Vector particles were produced in HEK 293T
cells by transient cotransfection with modifications as previously
described (16). Briefly, HEK 293T cells were plated on 100-mm
plates in 15 ml of medium (2 106 cells/plate) and 24 h later
transfected with pLKO.1-tet-on-KLF5shRNA, pLKO.1-tet-on-
DSG2shRNA, or pLKO.1-tet-on plasmid DNA (7.5 g), pCD/
NL-BH*  helper plasmid DNA (5 g), and pLTR-G DNA (2.5
g) using Lipofectamine 2000 (ThermoFisher Scientific). The me-
dium was replaced, and virus particles released in the medium were
harvested 16 h after transfection. Caco-2 BBe cells (2 105 cells/
well) were plated on six-well plates, and 24 h later pLKO.1-tet-on-
KLF5shRNA, pLKO.1-tet-on-DSG2shRNA, or pLKO.1-tet-on vi-
ruses were added in medium containing 8 g/ml of polybrene (Sigma,
St. Louis, MO). Antibiotic-resistant colonies were selected in medium
containing 4 g/ml of puromycin dihydrochloride (Santa Cruz Bio-
technology, Dallas, TX) for two weeks. Clones of puromycin-resistant
colonies were pooled as the stable transduced control Caco-2 BBe cell
line (Caco-2 BBe pLKO.1), the stable inducible KLF5 knockdown
Caco-2 BBe cell line (Caco-2 BBe KLF5IND), or the stable induc-
ible DSG2 knockdown Caco-2 BBe cell line (Caco-2 BBe
DSG2IND).
Establishment of DSG2 overexpression in Caco-2 BBe KLF5 IND
cells. The DSG2 lentiviral activation particles and control lentiviral
activation particles were purchased from Santa Cruz Biotechnology.
Caco-2 BBe KLF5IND cells (2 105 cells/well) were seeded in
six-well plates and 24 h later transfected with DSG2 or control
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lentiviral activation particles in medium containing 8 g/ml of poly-
brene (Sigma). Antibiotic-resistant colonies were selected in medium
containing 4 g/ml of puromycin dihydrochloride, 300 g/ml of
Hygromycin B, and 1 g/ml Blasticidin S hydrochloride (Santa Cruz
Biotechnology) for two weeks. Clones of antibiotic-resistant colonies
were picked and expanded as the stable DSG2 overexpression Caco-2
BBe KLF5IND cell line (Caco-2 BBe KLF5IND DSG2) or the
control cell line (Caco-2 BBe KLF5IND EV).
Transepithelial electrical resistance measurement and paracellular
permeability assay. Caco-2 BBe cell lines were maintained in DMEM
containing 10% FBS and 1% penicillin-streptomycin with 4 g/ml
puromycin dihydrochloride. Caco-2 BBe cells were seeded in the
permeable Transwell inserts (0.4 m pore size, 12 mm diameter;
Corning, Pittston, PA) at the density of 7 104 cells/well. To induce
the expression of shRNAs, doxycycline hydrochloride (Sigma Al-
drich) was added to the medium on day 3 of the culture and
maintained for the remaining days of cell culture. The transepithelial
electrical resistance of the Caco-2 BBe monolayers was measured
every 3 or 4 days with an EVOM epithelial voltohmmeter and
ENDOHM-12 chamber (World Precision Instruments, Sarasota, FL)
using PBS as electrolyte. TEER is expressed by multiplying the
resistance with growth area of the inserts (·cm2). To measure
paracellular permeability, at the end point of the 28-day cell culture,
500 l of Hanks’ Balanced Salt Solution (HBSS; Cellgro) containing
1 mg/ml FITC-4 kDa dextran (Sigma) were added to the apical
chambers, and 1.5 ml of HBSS in the basal chambers of the Transwell
plate, and then incubated in the CO2 incubator for 4 h. Mice were
gavaged with 1 mg of FITC-4 kDa dextran solution 4 h before
euthanization. Cardiac blood was drawn, left coagulating for 30 min
at room temperature, and centrifuged to separate serum from blood
cells. The pass-through concentration of the fluorescent molecule in
HBSS or serum was quantified using a SpectraMax M3 microplate
reader (Molecular Devices, Sunnyvale, CA) with the following set-
tings: wavelength of excitation 485 nm, wavelength of emis-
sion 525 nm.
Western blot analysis. Cells were lysed in 1 Laemmli Buffer, and
proteins were resolved by SDS-PAGE and blotted on nitrocellulose
membrane. Blots were blocked with 5% nonfat milk dissolved in 50
mM Tris, 150 mM NaCl, and 0.05% Tween 20, pH 7.6 (TBST), buffer
for 1 h at room temperature. The membranes were incubated at 4°C
overnight with antibodies as listed in Table 1. Following washes with
TBST, membranes were then incubated with appropriate unconju-
gated secondary antibodies at room temperature for 1 h and then
incubated with appropriate horseradish peroxidase (HRP)-conjugated
tertiary antibodies after washes in between. For the probing of
GAPDH, only HRP-conjugated secondary antibody was used. The
membranes were washed with TBST and incubated with HRP sub-
strate for 2 min followed by film development.
Immunofluorescence staining. Paraffin-embedded Villin-CreERT2,
Klf5IND, Villin-Cre, and Klf5IS tissue sections were rehydrated with
xylene and ethanol gradients and pressure cooked to expose the
antigen epitope. Sections were blocked with 1% nonfat milk in
Tris-Tween-buffered saline and incubated with antibodies listed in
Table 1. Unconjugated chicken anti-rabbit and Alexa 488-labeled
donkey anti-chicken were diluted at 1:300 to detect KLF5 and DSG2
but unconjugated bovine anti-goat and Alexa-594 labeled goat anti-
bovine diluted at 1:300 to probe KLF5 and DSC2. The DNA was
counterstained with Hoechst dye. The fluorescence was visualized
using a Nikon Eclipse 90i microscope (Nikon), and images were
acquired and processed with NIS-Elements.
Caco-2 BBe cell lines that had been grown in Transwell inserts for
28 days were fixed with 3.7% paraformaldehyde and washed with
PBS. Epithelial monolayers were blocked with 10% horse serum
(ThermoFisher Scientific) in PBS at 37°C for 1 h and incubated at 4°C
overnight with primary antibodies listed in Table 1. Alexa 488-
conjugated goat anti-rabbit antibody diluted 1:300 was used to visu-
alize proteins at 37°C for 1 h. DNA was counterstained with 1 M
TO-PRO3 iodide (ThermoFisher Scientific) for 10 min at room
temperature, and then samples were mounted using the Prolong Gold
anti-fade mounting medium (ThermoFisher Scientific) and stored at
20°C in the dark until analyzed. The fluorescence was visualized
using a Zeiss 510 confocal microscope, and images were acquired and
processed with the LSM 5 Image Browser.
Quantitative RT-PCR. Total RNA was extracted from fresh mouse
tissues using the RNeasy Mini kit (Qiagen, Valencia, CA) in combi-
nation with the RNase-free DNase Set (Qiagen) according to the
manufacturer’s instructions. cDNA was synthesized using the Super-
script VILO cDNA synthesis kit (ThermoFisher Scientific). Quanti-
tative PCR with mouse colonic tissues was performed in triplicates
with primer sets for Hprt1 (catalog no. QT00166768; Qiagen), Klf5
(catalog no. QT01057756; Qiagen), Dsg2 (catalog no. QT00173257;
Qiagen), Dsc2 (catalog no. QT00156198; Qiagen), Cdh1, Ctnna1,
Ctnnb1, Tjp1, Ocln, F11r, Cldn2, and Cldn4 (primer sequences are
listed in Table 2). Products were amplified and detected with the
Power SYBR PCR Master Mix (ThermoFisher Scientific) on an
Eppendorf REALPLEX ep gradient S real-time PCR Mastercycler
according to the manufacturer’s instructions. Relative changes in
Table 1. List of antibodies used for Western blot analysis and immunofluorescence staining
Antibodies Catalog No. and Company Western Blot Analysis IF Staining
Rabbit anti-KLF5 sc-22797, Santa Cruz Biotechnology 1:1,000 diluted in 5% milk 1:200 diluted in 10% horse serum
Goat anti-KLF5 AF3758, R&D N/A 1:100 diluted in 1% milk
Rabbit anti-DSG2 GTX102508, GeneTex 1:1,000 diluted in 5% milk 1:200 diluted in 10% horse serum
Rabbit anti-DSG2 AB150372, Abcam N/A 1:200 diluted in 1% milk
Sheep anti-DSC2 AF4688, R&D 1:1,000 diluted in 5% milk 1:100 diluted in 10% horse serum for immunocytochemistry
1:100 diluted in 1% milk for immunohistochemistry
Mouse anti-GAPDH MAB374, EMD Millipore 1:5,000 diluted in 5% milk N/A
IF, immunofluorescence; KLF5, Krüppel-like factor 5; DSG, desmoglein-2; DSC2, desmocollin-2; N/A, not applicable.
Table 2. List of primer sequences used for quantitative
RT-PCR
Target Gene Primer Sequence
Cadherin 1 (Cdh1) Forward: 5=-CAGGTCTCCTCATGGCTTTGC-3=
Reverse: 5=-CTTCCGAAAAGAAGGCTGTCC-3=
Catenin-1 (Ctnna1) Forward: 5=-AAGTCTGGAGATTAGGACTCTGG-3=
Reverse: 5=-ACGGCCTCTCTTTTTATTAGACG-3=
Catenin-1 (Ctnnb1) Forward: 5=-ATGGAGCCGGACAGAAAAGC-3=
Reverse: 5=-CTTGCCACTCAGGGAAGGA-3=
Tight junction
protein 1 (Tjp1)
Forward: 5=-ACCACCAACCCGAGAAGAC-3=
Reverse: 5=-CAGGAGTCATGGACGCACA-3=
Occludin (Ocln) Forward: 5=-TTGAAAGTCCACCTCCTTACAGA-3=
Reverse: 5=-CCGGATAAAAAGAGTACGCTGG-3=
F11 receptor (F11r) Forward: 5=-TCTCTTCACGTCTATGATCCTGG-3=
Reverse: 5=-TTTGATGGACTCGTTCTCGGG-3=
Claudin 2 (Cldn2) Forward: 5=-CAACTGGTGGGCTACATCCTA-3=
Reverse: 5=-CCCTTGGAAAAGCCAACCG-3=
Claudin 4 (Cldn4) Forward: 5=-GTCCTGGGAATCTCCTTGGC-3=
Reverse: 5=-TCTGTGCCGTGACGATGTTG-3=
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expression were calculated based on the comparative CT (CT)
method (32) after normalization to Hprt1 control.
Transmission electron microscopy. Colonic tissues isolated from
Villin-CreERT2, Klf5IND, Villin-Cre, and Klf5IS mice and Caco-2
BBe cell lines that had been grown in Transwell inserts for 28 days
were fixed at 4°C overnight in 2.5% electron microscopy-grade
glutaraldehyde (Electron Microscopy Sciences, Hatfield, PA) in 0.1 M
PBS, pH 7.4. Samples were processed, and sections were prepared by
the Central Microscopy Imaging Center at Stony Brook University.
Sections were viewed with an FEI Tecnai12 BioTwinG2 transmis-
sion electron microscope. Images were acquired with an AMT
XR-60 CCD digital camera system and assembled using ImageJ
software (33).
Chromatin immunoprecipitation. Human DSG2 5=-flanking DNA
was amplified by PCR from yeast artificial chromosome clone 9G-C3
(Source BioScience). Plasmid pGL3BDSG2(500) contained bases
500 to 1 of DSG2 5=-flanking DNA. Because of low transfection
efficiency of the Caco-2 BBe cell line, 1 107 HEK 293T cells
instead were seeded in a 150-mm culture dish and transfected with
plasmids pMT3-HA-KLF5 and pGL3BDSG2(500). Later (24 h), cells
were cross-linked with 37% formaldehyde and lysed, DNA was
sheared (200–1,000 bp) by sonication, and fragments were incubated
with human influenza hemagglutinin (HA) antibody (Cell Signaling
Technology) and KLF5 rabbit polyclonal antibody developed by our
laboratory. The specific KLF5-binding regions were enriched with the
ChIP assay kit (Millipore, Billerica, MA) according to the manufac-
turer’s protocol. Amplification of DSG2 promotor sequence bound to
KLF5 was accomplished by PCR using the following primers: site 1
forward: 5=-TACTTGGTCCCGCAGGACTCT-3=, reverse: 5=-
CCCAAGGACAAAAGCTCCA-3=; site 2  3 forward: 5=-
GCTTTTGTCCTTGGGCCG-3=, reverse: 5=-ACTCTCTGGAG-
AATGGCGG-3=. DNA electrophoresis was performed in 4% agarose
gels.
DSG2 promoter analysis. Human DSG2 5=-flanking DNA was sub-
cloned into the pLightSwitch promoter reporter vector (ActiveMotif,
Carlsbad, CA) digested with KpnI and XhoI. Site-directed mutagenesis
was used to generate KLF5-binding site mutations MUT1, MUT2, and
MUT3. Because of low transfection efficiency of the Caco-2 BBe cell
line, HEK 293T cells instead were seeded in 96-well plates at the density
of 1 104 cells/well. Cells were transfected at 70% confluence with
pLightSwitch, pLightSwitch-DSG2(500), or KLF5-binding site mutant
constructs, in combination with pEGFP-EGFP or pEGFP-EGFP-
KLF5-HA, using Lipofectamine 2000. Later (1 day), luciferase activities
were determined with the LightSwitch Luciferase Assay System (Active
Motif). The firefly luciferase activity was quantified using a luminometer.
Statistical analysis. Statistical analysis was performed using
GraphPad Prism version 4.0 for Windows (GraphPad Software).
RESULTS
Dsg2 level and Dsc2 level are reduced in the colon of mice
with intestine-specific deletion of Klf5. To investigate the
relationship between KLF5 and intestinal barrier function in
vivo we used the Klf5IND mouse model. We injected Klf5IND
mice with 1 mg tamoxifen for five consecutive days to induce
Klf5 knockout (Fig. 1A) and collected and analyzed the tissues.
This time point represents the most severe phenotype in
Klf5IND mice as previously reported (26). Female Klf5IND
mice were more susceptible to Klf5 knockout than male
Klf5IND mice because of higher efficiency of Klf5 depletion
(unpublished data) and demonstrated significant pathogenesis,
characterized by anal bleeding and decreased body weight
compared with their littermates injected with corn oil for five
consecutive days and with Villin-CreERT2 mice injected
with corn oil or 1 mg tamoxifen for five consecutive days. We
observed gender-dependent efficiency of Klf5 deletion upon
tamoxifen treatment, with female mice demonstrating greater
level of KLF5 reduction by qPCR and immunohistochemistry
(data not shown). FITC-dextran permeability assay was per-
formed by gavage 4 h before collecting cardiac blood and
measuring FITC signal in serum. A threefold increase in FITC
concentration in serum was observed in female mice with
deleted Klf5 in intestines, whereas no changes in FITC-dextran
concentration in serum were observed between Villin-CreERT2
control mice treated with or without tamoxifen induction (Fig.
1B). We collected RNA from colonic tissues of corn oil-
injected and tamoxifen-injected mice and analyzed the levels
of cell junction component genes, such as Cdh1, Ctnna1,
Ctnnb1, Tjp1, Ocln, F11r, Cldn2, Cldn4, Dsg2, and Dsc2. As
shown in Fig. 1C, both Dsg2 and Dsc2 mRNA levels in
tamoxifen-treated Klf5IND mice were significantly reduced
compared with corn oil-treated mice but not altered in the
Villin-CreERT2 controls, whereas other cell junction genes did
not have the same response to Klf5 knockout as Dsg2 and
Dsc2. Reduced levels of Dsg2 mRNA and Dsc2 mRNA were
accompanied by decreased levels of DSG2 and DSC2 proteins,
respectively, as indicated by immunofluorescence double stain-
ing of KLF5 and DSG2 or DSC2 (Fig. 1D). DSG2 and DSC2
are the major desmosomal cadherin species expressed in intes-
tinal epithelium (30). DSG2 is a cell junction protein that is
highly expressed in the intestinal epithelium, and several lines
Fig. 1. Desmoglein-2 (DSG2) and desmocollin-2 (DSC2) are reduced and mislocalized, and accompanied by altered morphology of desmosomes in the colonic
tissue of tamoxifen-induced female Villin-CreERT2;Klf5fl/fl (Klf5IND) mice compared with the corn oil-injected control group, and Villin-CreERT2 mice. A: qPCR
analysis of Krüppel-like factor 5 (Klf5) mRNA expression levels was determined in corn oil-injected or tamoxifen-injected female Villin-CreERT2 and Klf5IND
mice, respectively. Data represent means	 SE (n  8), *P 
 0.05 and ***P 
 0.001 by Student’s t-test. B: fluorescein isothiocyanate (FITC)-dextran
concentrations in serum 4 h after gavage of 1mg FITC-4 kDa dextran solution. Data represent means	 SE (n  8), *P 
 0.05 by Student’s t-test. C: qPCR
analysis of Cdh1, Ctnna1, Ctnnb1, Tjp1, Ocln, F11r, Cldn2, Cldn4, Dsg2, and Dsc2 mRNA expression levels was performed on tissues from corn oil-injected
and tamoxifen-injected female Villin-CreERT2 or Klf5IND mice. Data represent means	 SE (n  8), **P 
 0.01 by Student’s t-test. D: immunofluorescence
staining of KLF5 (red) and DSG2 (green) (a–h), and KLF5 (green) and DSC2 (red) (i–p) in proximal colon and distal colon of corn oil-injected and
tamoxifen-injected Villin-CreERT2 and Klf5IND mice, respectively. DNA was counterstained with Hoechst dye. Images were taken at200 magnification. Scale
bars in proximal sections indicate 20 m, whereas scale bars in distal sections indicate 50 m. Yellow arrowheads indicate DSG2 or DSC2 staining on basolateral
membranes on the epithelial surface, whereas white arrowheads indicate DSG2 or DSC2 staining on the apical sides of the basolateral membranes in crypts.
Relative mean fluorescence intensity was quantified (q and r). Data represent means 	 SE (n  10), *P 
 0.05, **P 
 0.01, and ***P 
 0.001 by Student’s
t-test. E: transmission electron microscopy images showing changes in morphology of desmosomes in Klf5-depleted colonic tissue (d, 30,000 magnification)
compared with the controls (a–c, 30,000 magnification). White arrows indicate apical junctional complexes; yellow arrowheads indicate desmosomes. Scale
bars indicate 400 nm. F: quantitative analysis of the number of desmosomes in colonic cells of corn oil- or tamoxifen-injected Villin-CreERT2 and Klf5IND mice.
Data represent means	 SE (n  6 for corn oil-injected Villin-CreERT2, n  5 for tamoxifen-injected Villin-CreERT2, and n  8 for Klf5IND), ***P 
 0.001,
Student’s t-test. G: quantitative analysis of the width of the intercellular spaces between desmosomes in colonic cells of corn oil- or tamoxifen-injected
Villin-CreERT2 and Klf5IND mice. Data represent means	 SE (n  37 for corn oil-injected Villin-CreERT2, n  29 for tamoxifen-injected Villin-CreERT2,
n  42 for corn oil-injected Klf5IND, and n  15 for tamoxifen-injected Klf5IND), **P 
 0.01, Student’s t-test.
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of evidence have demonstrated a positive correlation between
DSG2 and barrier function (31, 35). In control mice, DSG2
staining was observed on both apical and basolateral compart-
ments of the membrane of epithelial cells on the epithelial
surface in colon, whereas DSG2 staining at the apical mem-
brane of epithelial cells was observed only in colonic crypts
(Fig. 1D, a–f). The immunofluorescence staining of DSG2
showed that its staining intensity is significantly reduced on the
apical membrane of epithelial cells in colonic crypts of tamox-
ifen-treated Klf5IND mice with diminished KLF5 staining
(Fig. 1D, g and h) compared with control mice, which was
verified by quantification of fluorescence intensity (Fig. 1Dq).
Immunofluorescence staining of DSC2 in corn oil (Fig. 1D, m
and n)- and tamoxifen-injected Klf5IND mouse colonic tissues
showed a significant reduction of DSC2 level and redistribu-
tion in proximal colon sections (Fig. 1Do) and only redistri-
bution in distal colon sections (Fig. 1Dp), also verified by
quantification of fluorescence intensity (Fig. 1Dr). These re-
sults demonstrate that KLF5 is required for the maintenance of
intestinal barrier function and that the level and pattern of both
Dsg2 and Dsc2 expression depend on the presence of KLF5 in
the Klf5IND mouse model. We examined the morphology of
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desmosomes in the colonic tissues of the animals using trans-
mission electron microscopy (TEM). The colonic cells of
Villin-CreERT2 mice and corn oil-injected Klf5IND mice fully
polarized in epithelial cells with abundant brush borders on the
apical surface, apical junctional complexes, and numerous
desmosomes (apical foci demonstrated in Fig. 1E). In contrast,
the colonic cells in tamoxifen-injected Klf5IND mice showed
dramatic alteration in desmosomal morphology: the number of
brush-border microvilli on the apical membranes was de-
creased (Fig. 1Ed). Furthermore, the structures of desmosomes
were disrupted in Klf5-depleted cells, manifested by decreased
desmosome numbers and an enlarged intercellular space be-
tween adjacent plasma membranes. We further quantified the
number of desmosomes on the basolateral membrane. The
average number of desmosomes on each basolateral plasma
membrane per section was close to six in Villin-CreERT2
controls and corn oil-injected Klf5IND mice, but the number
was reduced to two in tamoxifen-injected Klf5IND mice (Fig.
1F). The average width of intercellular gap between desmo-
some plaques of cells in tamoxifen-injected Klf5IND mice was
40% wider than those of the controls (Fig. 1G). In contrast,
the structure and distribution of apical junctional complexes
were maintained upon Klf5 knockout. These results suggest
that the observed changes in epithelial morphology resulting
from KLF5 loss could be attributed to decreased numbers of
desmosomes and structural alterations.
Previous studies demonstrated increased gut permeability
using FITC-dextran assay in the Klf5IS mouse model regard-
less of gender (22). Two-thirds of Klf5IS mice died shortly
after birth, whereas adult surviving mice were sacrificed on day
37 after birth when they demonstrated severe characteristics of
Klf5 knockout as previously reported. We analyzed mRNA
levels of Klf5, Dsg2, and Dsc2 and discovered that Dsg2
mRNA level was significantly reduced and Dsc2 mRNA level
had an insignificant reduction in Klf5 knockout mouse tissues
compared with control tissues (Fig. 2A). Using immunofluo-
rescent staining, we observed that DSG2 staining was altered
in Klf5IS distal colon (Fig. 2Bd) in the same pattern as
observed in tamoxifen-injected female Klf5IND mouse colons.
The quantification of fluorescence intensity demonstrated that
DSG2 levels were significantly reduced in Klf5IS distal colon
sections compared with the control, whereas the reduction was
not significant in proximal sections (Fig. 2Bi). However, DSC2
staining intensities (Fig. 2Bj) and patterns are not obviously
different between Klf5IS and Villin-Cre tissues (Fig. 2B, e–h),
which is consistent with the lack of significant decrease in its
mRNA levels (Fig. 2A). Similar morphological changes illus-
trated by TEM are shown in Fig. 2C, and similar changes in
desmosome number and intercellular gap between desmosomal
plaques are shown in Fig. 2, D and E, respectively.
KLF5 is required for the maintenance of epithelial barrier
function in Caco-2 BBe cells. To confirm the role of KLF5 in
maintaining epithelial barrier function in vitro, we established
an inducible KLF5 knockdown cell line, Caco-2 BBe
KLF5IND, as described in MATERIALS AND METHODS. We
seeded Caco-2 BBe cells in permeable Transwell plates and
grew them for 3 days until confluence was achieved. On the
3rd day of the culture, we added doxycycline to induce expres-
sion of KLF5 shRNAs to commence KLF5 knockdown. Sam-
ples were collected on day 28 when the TEER values reached
the plateau phase in control cells. Western blot analysis of cell
lysates collected from the epithelial cell monolayers confirmed
the successful inhibition of KLF5 expression in doxycycline-
treated Caco-2 BBe KLF5IND but not the control cell line
Caco-2BBe pLKO.1 (Fig. 3, A and B). The development of
TEER was significantly impeded in doxycycline-treated
Caco-2 BBe KLF5IND cells (designated as DOX) com-
pared with the water-treated Caco-2 BBe KLF5IND cells
(designated as –DOX), and pLKO.1 groups. TEER reached a
plateau of 7.6 ·cm2 on the 28th day of treatment in Caco-2 BBe
KLF5IND DOX cells, 27.8 ·cm2 in the Caco-2 BBe
KLF5IND –DOX cells, 27.8 ·cm2 in the Caco-2 BBe pLKO.1
–DOX cells, and 32.0 ·cm2 in the Caco-2 BBe pLKO.1DOX
cells (Fig. 3C). Consistent with the difference in TEER values on
day 28 of culture, the pass-through concentrations of FITC-4 kDa
dextran molecules across the Caco-2 BBe KLF5IND DOX
monolayers were approximately fivefold higher than those across
the Caco-2 BBe KLF5IND –DOX monolayers, whereas the
pLKO.1 group did not show significant differences between
DOX and –DOX treatments (Fig. 3D). These results demon-
strate that KLF5 knockdown diminishes the integrity of barrier
function of Caco-2 BBe cells, resulting in increased permeability.
DSG2 but not DSC2 expression is significantly reduced in
KLF5 knockdown Caco-2 BBe cells. To assess the difference in
protein levels of DSG2 and DSC2, we analyzed protein ex-
tracts from Caco-2 BBe KLF5IND –DOX and Caco-2 BBe
KLF5IND DOX cells cultured for 28 days in Transwell
plates. Our results show that DSG2 protein levels were signif-
icantly lower in Caco-2 BBe KLF5IND DOX compared
with control, whereas DSC2 protein levels were not changed
(Fig. 4, A and B). Furthermore, we confirmed the absence of
DSG2 and the unaltered expression and distribution of DSC2
in Caco-2 BBe KLF5IND DOX cells using immunofluo-
rescence staining. In contrast to specific localization of DSG2
on basolateral membranes in Caco-2 BBe KLF5IND –DOX
cells as well as Caco-2 pLKO.1 –DOX and DOX cells, we
observed negligible staining in Caco-2 BBe KLF5IND
DOX cells (Fig. 4C, d and i). However, DSC2 is distributed
on basolateral membranes in Caco-2 BBe KLF5IND –DOX
cells as well as pLKO.1 –DOX andDOX cells (Fig. 4C, e–g)
but slightly redistributed to the cytoplasm of Caco-2 BBe
KLF5IND DOX cells (Fig. 4Ch). The fluorescence inten-
sity quantification did not show a statistically significant dif-
ference in DSC2 level between controls and KLF5 knockdown
cells (Fig. 4Cj). Taken together these results show that knock-
down of KLF5 decreases DSG2 expression but does not affect
DSC2 protein level.
Desmosome structure is disrupted in Caco-2 BBe
KLF5IND DOX cells. DSG2 and DSC2 are two major
transmembrane desmosomal cadherin proteins expressed in
human intestinal epithelium (30). Therefore, the loss of DSG2
could affect the structure or number of desmosomes in the
intercellular junctions. We examined the morphology of des-
mosomes in Caco-2 BBe KLF5IND –DOX and KLF5IND
DOX cells after 28 days of growth in permeable inserts using
TEM. The Caco-2 BBe KLF5IND –DOX and pLKO.1 –DOX
and DOX cells fully polarized into columnar epithelial cells
with abundant brush borders on the apical surface, apical
junctional complexes, and numerous desmosomes (apical foci
demonstrated in Fig. 4D, a–c). In contrast, the epithelial
monolayers of Caco-2 BBe KLF5IND DOX cells showed
dramatic alteration in morphology (Fig. 4Dd). Caco-2 BBe
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Fig. 2. DSG2 is reduced and mislocalized and
morphology of desmosomes is altered in the co-
lonic tissue of Klf5IS mice. A: qPCR analysis of
Klf5, Dsg2, and Dsc2 mRNA expression levels
was performed on tissues from in Villin-Cre mice
and Klf5IS mice. Data represent means 	 SE
(n  6 for control, and n  5 for Klf5IS), **P 

0.01 and ***P 
 0.001 by Student’s t-test. B:
immunofluorescence staining of KLF5 (magenta)
and DSG2 (green) (a–d) and KLF5 (green) and
DSC2 (magenta) (e–h) in proximal colon and
distal colon of control and Klf5IS mice. DNA was
counterstained with Hoechst dye. Images were
taken at 200 magnification. Scale bars in proxi-
mal sections indicate 20 m, whereas scale bars in
distal sections indicate 50 m. Yellow arrowheads
indicate DSG2 or DSC2 staining on basolateral
membranes on the epithelial surface, whereas
white arrowheads indicate DSG2 or DSC2 stain-
ing on the apical sides of the basolateral mem-
branes in crypts. Relative mean fluorescence in-
tensity was quantified (i and j). Data represent
means 	 SE (n 10), ***P
 0.001 by Student’s
t-test. C: transmission electron microscopy images
showing changes in morphology of desmosomes
in Klf5-depleted colonic tissue (a, 30,000 mag-
nification) compared with the control (b, 30,000
magnification). White arrows indicate apical junc-
tional complexes; yellow arrowheads indicate des-
mosomes. Scale bars indicate 400 nm. D: quanti-
tative analysis of the number of desmosomes in
colonic cells of Villin-Cre and Klf5IS mice. Data
represent means	 SE (n  4), ***P 
 0.001,
Student’s t-test. E: quantitative analysis of the
width of the intercellular spaces between desmo-
somes in colonic cells of Villin-Cre and Klf5IS
mice. Data represent means	 SE (n 8), ***P

0.001, Student’s t-test.
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KLF5IND DOX cells failed to polarize, and the number of
brush-border microvilli on the apical membranes was de-
creased. Furthermore, the images also indicated that the struc-
tures of desmosomes were disrupted in Caco-2 BBe
KLF5IND DOX cells, manifested by bulgy desmosome
plaques and an enlarged intercellular space between adjacent
plasma membranes. We further quantified the number of des-
mosomes on the basolateral membrane. The average number of
desmosomes on each basolateral plasma membrane per section
was between five and six in Caco-2 BBe KLF5IND –DOX
and pLKO.1 –DOX andDOX cells, whereas the number was
decreased to three in Caco-2 BBe KLF5IND DOX cells
(Fig. 4E). The average width of intercellular gap between
desmosome plaques of Caco-2 BBe KLF5IND DOX cells
was 40% wider than that of the control cells (Fig. 4F). In
contrast, the structure and distribution of apical junctional
complexes were maintained upon KLF5 knockdown. These
results suggest that the observed changes in epithelial morphol-
ogy resulting from KLF5 loss could be attributed to decreased
numbers of desmosomes and structural alterations in those
present.
DSG2 is required for KLF5-mediated maintenance of epi-
thelial barrier function. To verify that DSG2 plays a role in
KLF5-mediated maintenance of the epithelial barrier function,
we studied the barrier function of inducible DSG2 knockdown
Caco-2 BBe cells in absence (Caco-2 BBe DSG2IND –DOX)
or presence (Caco-2 BBe DSG2INDDOX) of doxycycline.
Cells were seeded in permeable Transwell plates and grown for
3 days until confluence was achieved, and doxycycline was
added on day 3 and maintained as described in MATERIALS AND
METHODS. Western blot analysis of cell lysates collected from
the epithelial cell monolayers confirmed a 57% reduction in
DSG2 expression in Caco-2 BBe DSG2IND DOX com-
pared with –DOX cells (Fig. 5, A and B). TEER measurements
showed that the establishment of barrier function was signifi-
cantly impeded in Caco-2 BBe DSG2IND DOX cells com-
pared with the Caco-2 BBe DSG2IND –DOX. TEER reached
a plateau of 19.0 ·cm2 on the 28th day of treatment in Caco-2
BBe DSG2IND DOX cells and 71.0 ·cm2 in the water-
treated Caco-2 BBe DSG2IND cells (Fig. 5C). Consistently,
the pass-through concentrations of FITC-4 kDa dextran mole-
cules across the Caco-2 BBe DSG2IND DOX monolayers
were approximately ninefold higher than those across the
Caco-2 BBe DSG2IND –DOX monolayers (Fig. 5D). Immu-
nofluorescence staining of DSG2 showed reduced levels and
mislocalization of DSG2 in Caco-2 BBe DSG2IND DOX
compared with the membranous distribution of DSG2 in
Caco-2 BBe DSG2IND DOX cells (Fig. 5E, a and b),
verified by quantification of fluorescence intensity (Fig. 5Ec).
These results demonstrate that DSG2 knockdown impairs the
integrity of barrier function of Caco-2 BBe cells, resulting in
increased permeability, as demonstrated in Caco-2 BBe
KLF5IND DOX cells.
DSG2 overexpression partially rescues impaired epithelial
barrier function caused by KLF5 knockdown. To study
whether DSG2 is a major factor that plays a role in KLF5-
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Fig. 3. Epithelial barrier function is impaired
in KLF5 knockdown Caco-2 BBe cells.
Caco-2 BBe pLKO.1 cells and Caco-2 BBe
KLF5IND cells were seeded in Transwell
plates. On day 3 of the culture, cells were
treated with water or doxycycline to induce
expression of short-hairpin RNA (shRNA).
Cells were maintained for a total 28 days. A:
Western blot analysis of the KLF5 protein
levels in Caco-2 BBe KLF5IND –DOX
and Caco-2 BBe KLF5IND DOX cells
(bottom) and Caco-2 BBe pLKO.1 –DOX
and Caco-2 BBe pLKO.1 DOX cells (top)
on day 28. A result from 3 independent
experiments is shown. B: quantitative repre-
sentation of KLF5 protein levels in 3 indepen-
dent experiments, normalized to GAPDH.
Data represent means	 SE (n  3), ***P 

0.001, Student’s t-test. C: transepithelial
electrical resistances of Caco-2 BBe
KLF5IND (gray lines) and Caco-2 BBe
wild-type (WT, black lines) monolayers
grown in absence (–DOX, solid line) and
presence (DOX, broken line) of doxycy-
cline were measured during 28 days of cul-
ture. Data represent means	 SE (n  3),
*P 
 0.05, **P 
 0.01, and ***P 
 0.001,
Student’s t-test. D: permeability to FITC-4
kDa dextran measured on day 28. Data are
shown as pass-through concentrations of
FITC-dextran. Empty boxes, –DOX; filled
boxes, DOX. Data represent means	 SE
(n  3), **P 
 0.01 by Student’s t-test.
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mediated maintenance of epithelial barrier function, we studied
the barrier function of DSG2-overexpressing Caco-2 BBe
KLF5IND cells in the absence (Caco-2 BBe KLF5IND
DSG2 –DOX) or presence (Caco-2 BBe KLF5IND DSG2
DOX) of doxycycline, along with the control cell line in the
absence (Caco-2 BBe KLF5IND EV –DOX) or presence
(Caco-2 BBe KLF5IND EV DOX) of doxycycline. Cells
were seeded in permeable Transwell plates and grown for 3
days until confluence was achieved, and doxycycline was
added on day 3 and maintained as described in MATERIALS AND
METHODS. The TEER reached the maximum value on day 55
postseeding. TEER measurements during the time period of 55
days showed that the establishment of barrier function was
significantly impeded in Caco-2 BBe KLF5IND EV DOX
KLF5ΔINDpLKO.1
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Fig. 4. Expression of DSG2 but not DSC2 is reduced and desmosomal morphology is changed upon KLF5 knockdown in Caco-2 BBe cells. Caco-2 BBe pLKO.1
and KLF5IND cells were seeded in Transwell plates, and, on day 3 of the culture, cells were treated with water or doxycycline to induce expression of shRNA.
A: Western blot analysis of the DSG2 and DSC2 protein levels in Caco-2 BBe pLKO.1 –DOX and DOX and Caco-2 Bbe KLF5IND –DOX and DOX cells
(bottom) on day 28. A result from 3 independent experiments is shown. B: quantitative representation of DSG2 and DSC2 protein levels in 3 independent
experiments, normalized to GAPDH. Data represent means	 SE (n  3), ***P 
 0.001, Student’s t-test. C: immunofluorescence staining of DSG2 (a–d) and
DSC2 (e–h) in Caco-2 BBe pLKO.1 –DOX/DOX and Caco-2 BBe KLF5IND –DOX/DOX cells collected on day 28 of culture. The top part of each panel
shows X–Y projections obtained from Z-stacks, and companion Z-plane cross sections are shown on bottom. DNA was counterstained with TO-PRO3. Images
were taken at400 magnification. Scale bars indicate 20 m. Relative mean fluorescence intensity was quantified (i and j). Data represent means	 SE (n 
6), ***P 
 0.001 by Student’s t-test. D: transmission electron microscopy images showing different morphologies involving decreased microvilli numbers and
altered desmosome structures between Caco-2 BBe pLKO.1 –DOX/DOX, Caco-2 BBe KLF5IND –DOX (a–c, 30,000 magnification), and Caco-2 BBe
KLF5IND DOX cells (d, 30,000 magnification). White arrows, apical junctional complexes; yellow arrowheads, desmosomes. Scale bars indicate 400 nm.
E: quantitative analysis of the number of desmosomes in Caco-2 BBe pLKO.1 –DOX/DOX, Caco-2 BBe KLF5IND –DOX, and Caco-2 BBe KLF5IND
DOX cells. Data represent means 	 SE (n 4 for pLKO.1 –DOX, n 8 for pLKO.1DOX, n 4 for Caco-2 BBe KLF5IND –DOX, and n 5 for Caco-2
BBe KLF5IND DOX), **P 
 0.01, Student’s t-test. F: quantitative analysis of the width of the intercellular spaces between desmosomes in Caco-2 BBe
KLF5IND –DOX and Caco-2 BBe KLF5IND DOX cells. Data represent means 	 SE (n  26 for pLKO.1 –DOX, n  42 for pLKO.1 DOX, n  12
for Caco-2 BBe KLF5IND –DOX, and n  8 for Caco-2 BBe KLF5IND DOX), **P 
 0.01, Student’s t-test.
G486 KLF5 AND INTESTINAL BARRIER FUNCTION
AJP-Gastrointest Liver Physiol • doi:10.1152/ajpgi.00172.2017 • www.ajpgi.org
 by 10.220.32.247 on Novem
ber 17, 2017
http://ajpgi.physiology.org/
D
ow
nloaded from
 
cells compared with Caco-2 BBe KLF5IND EV –DOX.
DSG2 overexpression enhanced barrier function in Caco-2
BBe KLF5IND DSG2 –DOX and partially rescued the im-
paired barrier function in Caco-2 BBe KLF5IND DSG2
DOX. TEER reached a plateau of 47.7 ·cm2 on the 55th
day of treatment in Caco-2 BBe KLF5IND EV –DOX cells,
6.8 ·cm2 in Caco-2 BBe KLF5IND EV DOX cells, 69.2
·cm2 in Caco-2 BBe KLF5IND DSG2 –DOX cells, and 18.0
·cm2 in Caco-2 BBe KLF5IND DSG2 DOX cells (Fig.
6A). Consistently, the pass-through concentrations of FITC-4
kDa dextran molecules across the Caco-2 BBe KLF5IND
DSG2 DOX monolayers were approximately sevenfold
higher than those across the Caco-2 BBe KLF5IND DSG2
–DOX monolayers, in contrast to the ninefold increase in
Caco-2 BBe KLF5IND EV DOX compared with Caco-2
BBe KLF5IND EV –DOX (Fig. 6B). Immunofluorescence
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Fig. 5. Epithelial barrier function is impaired in
DSG2 knockdown Caco-2 BBe cells. Caco-2
BBe DSG2IND cells were seeded in Transwell
plates. On day 3 of the culture, cells were treated
with water or doxycycline to induce expression
of shRNA. Cells were maintained for a total of
28 days. A: Western blot analysis of the DSG2
protein levels in Caco-2 BBe DSG2IND –DOX
and Caco-2 BBe DSG2IND DOX cells (bot-
tom) on day 28. A result from 3 independent
experiments is shown. B: quantitative represen-
tation of DSG2 protein levels in 3 independent
experiments, normalized to GAPDH. Data rep-
resent means	 SE (n  3), **P 
 0.01, Stu-
dent’s t-test. C: transepithelial electrical resis-
tances of Caco-2 BBe DSG2IND monolayers
grown in absence (–DOX, solid line) and pres-
ence (DOX, broken line) of doxycycline were
measured during 28 days of culture. Data repre-
sent means	 SE (n  6), ***P 
 0.001, Stu-
dent’s t-test. D: permeability to FITC-4 kDa
dextran measured on day 28. Data are shown as
pass-through concentrations of FITC-dextran.
Empty boxes, –DOX; filled boxes, DOX. Data
represent means	 SE (n 6), ***P
 0.001 by
Student’s t-test. E: immunofluorescence staining
of DSG2 in Caco-2 BBe DSG2IND –DOX and
Caco-2 BBe DSG2IND DOX cells collected
on day 28 of culture. The top part of each panel
shows X–Y projections obtained from Z-stacks,
and companion Z-plane cross sections are shown
on bottom. DNA was counterstained with TO-
PRO3. Images were taken at400 magnifica-
tion. Scale bars indicate 20 m. Relative mean
fluorescence intensity was quantified (c). Data
represent means	 SE (n 6), ***P
 0.001 by
Student’s t-test.
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staining of DSG2 showed reduced levels and mislocalization of
DSG2 in Caco-2 BBe KLF5IND EV DOX (Fig. 6Cb)
compared with the membranous distribution of DSG2 in
Caco-2 BBe KLF5IND EV –DOX cells (Fig. 6Ca), and
slightly increased level of DSG2 by 30% in Caco-2 BBe
KLF5IND DSG2 –DOX cells (Fig. 6Ce), accompanied with a
thick monolayer of mature columnar epithelial cells (Fig. 6Cc).
DSG2 was partially restored by 10% on cell membranes in
Caco-2 BBe KLF5IND DSG2DOX cells (Fig. 6C, d and e).
These results demonstrate that DSG2 overexpression partially
rescues the barrier function of Caco-2 BBe cells upon KLF5
knockdown and increases the epithelial barrier function of
Caco-2 BBe on a basal level.
KLF5 regulates DSG2 promoter activity. Potential KLF5-
binding sites were identified with the KLF5-binding motifs
identified in a previous study (28) (Fig. 7A), and ChIP study
showed that KLF5 interacts with all of the promoter sequences
that cover the potential KLF5-binding sites (Fig. 7B). Muta-
tions were introduced in respective KLF5-binding sites, and
the sequences are listed in Fig. 7B. Because of the endogenous
KLF5 expression in HEK 293T cells, DSG2 promoter has a
high basal level activity. Mutant DSG2 promoter MUT1 has a
similar basal level as the wild-type DSG2 promoter, but KLF5
overexpression failed to enhance the promoter activity; MUT2
and MUT3 showed decreased basal levels of promoter activi-
ties, and the KLF5-mediated transactivation of DSG2 promoter
was partially impaired (Fig. 7C). These results indicated a
direct interaction of KLF5 and DSG2 promoter at multiple
binding sites, and site 1 is crucial for KLF5-mediated transac-
tivation of DSG2 promoter.
DISCUSSION
KLF5 is highly expressed in the proliferative compartment
of small intestine and colon, and previous studies from our
laboratory demonstrated that KLF5 is required for the mainte-
nance of the crypt architecture and barrier function in the
mouse intestine (22). Herein we investigated the mechanisms
by which KLF5 regulates colonic barrier function.
We have previously shown that inducible intestine-specific
deletion of Klf5 in adult mice caused signs of epithelial distress
in colonic tissues (26). In colonic tissues collected from the
corn oil- or tamoxifen-injected 8-wk-old adult female Klf5IND
mice and the 5-wk-old adult Villin-Cre and Klf5IS mice, a
A
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Fig. 6. Overexpression of DSG2 partially res-
cues impaired barrier function upon KLF5
knockdown in Caco-2 BBe cells. Caco-2 BBe
KLF5IND EV and KLF5IND DSG2 cells
were seeded in Transwell plates, and, on day 3
of the culture, cells were treated with water or
doxycycline to induce expression of shRNA.
Cells were maintained for a total 55 days. A:
transepithelial electrical resistances of Caco-2
BBe KLF5IND EV (black lines) and Caco-2
BBe KLF5IND DSG2 (gray lines) monolay-
ers grown in absence (–DOX, solid line) and
presence (DOX, broken line) of doxycycline
were measured during 55 days of culture. Data
represent means	 SE (n  3), *P 
 0.05 and
***P 
 0.001, Student’s t-test. B: permeability
to FITC-4 kDa dextran measured on day 55.
Data are shown as pass-through concentrations
of FITC-dextran. Empty boxes, –DOX; filled
boxes, DOX. Data represent means	 SE
(n  3), **P 
 0.01 and ***P 
 0.001 by
Student’s t-test. C: immunofluorescence stain-
ing of DSG2 in Caco-2 BBe KLF5IND EV
–DOX (a)/DOX (b) and Caco-2 BBe
KLF5IND DSG2 –DOX (c)/DOX (d) cells
collected on day 55 of culture. The top part of
each panel shows X–Y projections obtained
from Z-stacks, and companion Z-plane cross
sections are shown on bottom. DNA was coun-
terstained with TO-PRO3. Images were taken
at 400 magnification. Scale bars indicate 20
m. Relative mean fluorescence intensity was
quantified (e). Data represent means 	 SE (n
6), *P 
 0.05 and ***P 
 0.001 by Student’s
t-test.
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correlation of KLF5 and DSG2 is discovered. KLF5 and DSG2
are highly expressed in human colon cancer tissues (39), and
DSG2 levels in the KLF5-positive crypts in Klf5IS tissues
resulting from variegated Klf5 knockout are higher than that in
Klf5-depleted crypts (data not shown); thus, it is likely that
KLF5 and DSG2 levels have a direct positive correlation. The
KLF5-dependent expression of DSG2 could explain the find-
ings of many studies that addressed their physiological func-
tions, ranging from embryonic development to inflammatory
bowel diseases and tumorigenesis. Dsg2/ mouse embryos
and some Dsg2/ embryos died at the blastocyst stage of
embryonic development because of defective implantation (8).
Moreover, embryonal stem cells derived from Dsg2/ em-
bryos were eliminated by day 6 in culture, indicating that
DSG2 is essential for embryonal stem cell growth (8). Impor-
tantly, similar phenotypes were reported for Klf5/ mouse
embryos (29). Another genome-wide ChIP and microarray
study on Klf5 knockdown in embryonic stem cells showed that
expression of Dsg2 is downregulated upon siKlf5 transfection
(28). These results suggest potential overlapping functions of
KLF5 and DSG2 in the development of mouse embryonic stem
cells. Additionally, loss of both DSG2 and DSC2 in SK-CO15
cells has been studied and indicated that reduced DSG2 level
inhibits cell proliferation via epidermal growth factor receptor
signaling (13), which aligns with the proproliferative effect of
KLF5 on intestinal epithelial cells harboring activated KRAS
mutation (24). Furthermore, our preliminary results from short-
term experiments show that deletion of DSG2 in Caco2 cells
decreases, however not significantly, proliferation of these
cells compared with control (data not shown). Studies have
also demonstrated a decrease in both KLF5 and DSG2 expres-
sion in colonic tissues from patients with inflammatory bowel
disease (35, 43). These results support the hypothesis that loss
of KLF5 in the intestinal epithelium can result in decrease of
DSG2 expression and lead to loss of barrier function and
inflammation that are the hallmark of inflammatory conditions,
e.g., in Crohn’s disease. Our data demonstrate that the basal
expression levels of the desmosomal cadherins Dsg1, -3, and -4
and Dsc1 and -3 are undetectable in control and Klf5IS mouse
animal models, and cytokeratin-8 and -18, components of
intermediate filament, are not changed upon Klf5 deletion (data
not shown). mRNA levels of other cell junction components
such as E-cadherin, -catenin, -catenin, ZO-1, occludin,
JAM-A, claudin-2, claudin-4, and claudin-12 were not primar-
ily changed by Klf5 knockout.
Previous studies from our laboratory showed that KLF5
promotes proliferation of cultured cells (24). To minimize the
potential effects of slowed cell proliferation caused by KLF5
knockdown, we used the inducible KLF5 knockdown cell line
and did not induce knockdown until cells had reached conflu-
ence, between days 3 and 4 after seeding. Therefore, it is
unlikely that the impaired barrier function is merely because of
KLF5=s effect on cell proliferation. Our evidence strongly
suggests that the effect of KLF5 on barrier function is because
of its regulation of cell junctions and subsequent changes in
epithelial morphology.
We showed a correlation of DSG2 and KLF5 levels in the
Caco-2 BBe cell line, consistent with our in vivo observations.
Several studies have demonstrated that DSG2 is essential for
maintaining the integrity of intestinal epithelial barrier. For
example, a DSG2 antibody that detects the extracellular do-
main specifically blocks DSG2 interaction in the cell-free
system and significantly increases epithelial permeability of
Caco-2 cells (31). IL-10-mediated enhancement of the epithe-
lial barrier in the presence of corticosteroids is also accompa-
nied by an increase in DSG2 expression, whereas its expres-
sion is reduced in colonic epithelial cells of glucocorticoid-
refractory patients (19). A study on human ulcerative colitis
and Crohn’s disease patient tissues showed that the distribution
and intensity of DSG2 staining were not strikingly different in
noninflamed tissues from that seen in control tissue but were
significantly reduced in inflamed mucosal tissues (35). Our
A
3TUM1TUM 2TUMWT
In
pu
t
Ig
G
A
nt
i-H
A
A
nt
i-K
LF
5
Site 1
Site 2&3
B C
Mutant 1: CCGCAGGAC ACATAGTAC
Mutant 2: CAGGTCGAG TATATATAG
Mutant 3: CGCCAGGAG TACTAGTTG 0
10
20
30
35
D
SG
2 
Pr
om
ot
er
 A
ct
iv
ity
 
C
ha
ng
e 
Fo
ld
**
* **
**
25
15
5
EV
KLF5
Fig. 7. KLF5-binding sites are identified in
DSG2 promoter. A: sequences of the potential
binding sites for KLF5 are shown in gray and
italic within 500 bp upstream of the start codon
of DSG2, with transcript underlined. B: PCR
products of DSG2 promoter sequences in input
cell lysates and immunoprecipitations with rab-
bit IgG, rabbit HA antibody, and KLF5 antibody
using HEK 293T cells cotransfected with
pGL3BDSG2(500) and pMT3-HA-KLF5. Se-
quences of the site-directed mutation of the
binding sites are shown. C: DSG2 promoter
activity measured with luciferase assay. HEK
293T cells were transfected pEGFP-EGFP
or pEGFP-EGFP-KLF5-HA together with
pLightSwitch, pLightSwitch-DSG2(500), or
pLightSwitch-DSG2(500) mutant promoter re-
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results also confirmed the role of DSG2 in barrier function by
knocking down DSG2 in Caco-2 BBe cells. However, overex-
pression of DSG2 could not completely rescue the impaired
barrier function in KLF5 knockdown Caco-2 BBe cells, sug-
gesting that DSG2 might not be the only factor that KLF5
affects to maintain barrier function. Additionally, we analyzed
the mRNA levels of several tight/adherent junction proteins
(TJP1, OCLN, CLDN4, and CDH1) in DSG2 knockdown cells
but did not observe any significant decrease (data not shown).
Taken together, these results indicate that DSG2 exerts an
important role in regulating intestinal barrier function.
Because DSG2 was significantly decreased in Caco-2 BBe
KLF5IND DOX cells, DSG2 may be an effector of KLF5-
mediated epithelial barrier function. Loss of DSG2 is accom-
panied by altered desmosome structures and number. Many
studies on desmosomes reported that desmosome assembly is
sensitive to isoform-specific differences exhibited by desmo-
somal cadherins and that desmogleins and desmocollins inter-
act in a heterophilic manner in mature desmosomes (6, 20).
Although DSC2 can compensate for the loss of DSG2 from
desmosomes to some extent in the colon cancer cell line
SK-CO15 (13), the expression and distribution of DSC2 is not
changed by KLF5 knockdown in our Caco-2 BBe cell system
and Klf5IS mouse model. The reduction of DSC2 levels in
tamoxifen-induced Klf5IND mice could be because of a sec-
ondary response to the loss of DSG2 from the DSG2-DSC2
heterodimers, whereas DSC2 can be stabilized in DSC2 ho-
modimers that might be a major form of desmosomal cadherin
dimers in Klf5IS mouse tissues to compensate for the loss of
DSG2. The other possible reason goes to the fact that the adult
Klf5IS mice used for experiments were survivors who had
partial expression of KLF5. Functional studies on models of
DSG2 knockdown further substantiated the effector role of
DSG2 in KLF5-mediated establishment of epithelial barrier
function.
Because of its transcription role, a majority of studies on
KLF5 are focused on transcription regulation of potential
KLF5 target genes. Having screened the KLF5-binding motifs
identified in a study that combined genome-wide ChIP and
microarray analysis (28), we identified three KLF5-binding
motifs within the 500-bp region of DSG2 promoter compared
with none within HPRT1 promoter. Consistently, our ChIP
results and promoter study showed a positive effect of KLF5 in
activating the DSG2 promoter, indicating that KLF5 regulates
DSG2 expression by serving as a direct transcription activator
of the DSG2 gene. The unexpected unchanged basal level of
DSG2 promoter mutant at site 1 can be the result of the
potential transactivation by other transcription factors. Because
the promoter activity of mutant at site 1 was not enhanced by
KLF5 overexpression, site 1 could be the major binding site for
KLF5; sites 2 and 3 are in tandem, and mutation on one of
them just partially depleted DSG2 promoter KLF5-mediated
transactivation; thus, these two sites might work in combina-
tion for KLF5 binding.
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